Target intelligence / Profile preview

Zinc-dependent enzymes and zinc-binding proteins

Molecular classification
Enzyme, Transcription factor, Metalloprotein
01

Overview

Zinc-dependent enzymes and zinc-binding proteins constitute a large and diverse group of proteins where zinc ions play essential catalytic, structural, or regulatory roles (Maret, 2013, Metallomics). Zinc serves as a cofactor for approximately 10% of the human proteome, including critical enzymes such as carbonic anhydrases, matrix metalloproteinases (MMPs), and histone deacetylases (HDACs) (Andreini et al., 2006, Journal of Proteome Research). These proteins are involved in a wide array of biological processes, ranging from DNA replication and gene expression to metabolism and signal transduction (Vallee & Falchuk, 1993, Physiological Reviews). In disease states, dysregulation of zinc-binding proteins is linked to cancer, cardiovascular disorders, and neurodegeneration (Watt et al., 2010, Frontiers in Bioscience). Therapeutic strategies often involve small-molecule inhibitors that bind to the zinc ion within the protein's active site, effectively blocking its function (Chen et al., 2019, Journal of Medicinal Chemistry). However, the ubiquity of zinc-binding motifs across various protein families presents a significant challenge for drug design, as achieving high specificity is necessary to minimize adverse effects (Parkin, 2004, Chemical Communications).

Other names
MetalloproteinsZinc-binding proteinsZinc-dependent enzymesZinc finger proteins
02

Mechanism of action

Drugs typically interact with these targets by chelating the zinc ion in the active site or by displacing the water molecule coordinated to the zinc, thereby inhibiting enzymatic activity or disrupting structural motifs like zinc fingers (Chen et al., 2019, Journal of Medicinal Chemistry).

03

Biological functions

CatalysisDNA bindingGene expression regulationStructural stabilitySignal transduction
04

Disease associations

CancerInflammationNeurodegenerative diseaseCardiovascular diseaseInfection
05

Safety considerations

Lack of selectivity leading to off-target effectsSystemic zinc deficiencyPotential for metal chelation-related toxicity (Parkin, 2004, Chemical Communications)
06

Interacting drugs

Vorinostat

4 more in the full profile.

07

Biomarkers

Serum zinc levelsEnzyme activity assays (e.g., ACE activity)Matrix metalloproteinase levels

Beyond the preview

Go deeper on Zinc-dependent enzymes and zinc-binding proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc-dependent enzymes and zinc-binding proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call